title: Relative roles of bone scintigraphy and positron emission tomography in assessing the treatment response of bone metastases.
authors.forename: J R
authors.initials: JR
authors.lastname: García
authors.forename: M
authors.initials: M
authors.lastname: Simó
authors.forename: M
authors.initials: M
authors.lastname: Soler
authors.forename: G
authors.initials: G
authors.lastname: Pérez
authors.forename: S
authors.initials: S
authors.lastname: López
authors.forename: F
authors.initials: F
authors.lastname: Lomeña
mesh_terms: D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary* / Q000628:therapy; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013669:Technetium Tc 99m Medronate; D016896:Treatment Outcome
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D013669:Technetium Tc 99m Medronate